What is multi-dose packaging?
Multi-dose packaging places all the medications a patient takes at one administration time into a single sealed, labelled package. A patient taking six medications across four times of day receives four packages per day rather than managing six containers, and each package is labelled with the patient, the contents and the time it is due.
The unit of organisation changes from the drug to the moment. That is the entire idea, and most of the consequences follow from it.
What problem does it solve?
Sorting, and the errors that come from doing it repeatedly. A patient on multiple chronic medications performs a small assembly task several times a day, every day, indefinitely — and the error rate of a repeated manual sort is a function of how many times it has been done and how well the person doing it feels that morning.
It also makes non-adherence visible. An unopened package is unambiguous evidence that a dose was not taken at that time, which is a considerably better signal than counting what is left in a bottle. For anyone supervising medication from a distance — a caregiver, a community nurse, a follow-up programme — that is the difference between observing and inferring.
And in a facility, it removes the preparation step from the med pass. A nurse arriving at a resident with the correct package already assembled is doing a different and shorter task than a nurse assembling it at a trolley.
Who does it genuinely suit?
The fit is narrower than the marketing suggests, and being precise about it is useful to everyone.
Stable chronic regimens
Several solid oral medications, taken at fixed times, unchanged for weeks. This is the case the format was designed for and it works well.
Patients with cognitive difficulty
Where the sorting task itself is the barrier rather than the willingness. A package labelled with a day and a time asks much less of someone than seven bottles and a printed schedule.
Supervised administration in a facility
Long-term care, assisted living, rehabilitation. The preparation and the administration are done by different people at different times, and a sealed labelled package is what carries the identity between them.
Anyone whose adherence needs to be observable
Post-discharge, complex therapy, a patient a care team is genuinely worried about. The unopened package is the observation.
When is it the wrong choice?
Frequently changing regimens. Every change invalidates the packages already made, and the resolution is either a re-pack or a nurse opening a sealed package to remove a tablet. The second one is common, understandable, and it destroys the integrity the format existed to provide — after it, the label describes contents that are no longer inside.
Anything taken as needed. A PRN analgesic does not belong to a scheduled administration time, so it lives outside the packaging and has to be managed separately. A patient with several PRN medications ends up running two systems, which is more complex than the one they started with.
Medications that cannot be co-packaged. Some products are hygroscopic, light-sensitive, or unstable outside their original packaging, and some require the original container by regulation. A vendor who does not raise this unprompted has not thought about it.
And patients who genuinely manage well already. Replacing a working system with a different working system has a cost and no benefit, and packaging is sometimes sold as a solution to a problem the patient did not have.
What does multi-dose packaging not fix?
It does not confirm the dose was taken. An opened package is evidence the package was opened. This sounds pedantic and matters: it is the reason packaging alone is a weaker adherence intervention than it appears, and the reason it works best combined with contact rather than instead of it.
It does not address why someone stops. Of the four reasons patients abandon a chronic medication — forgetting, a side-effect, cost, and a considered decision that it is unnecessary — packaging addresses one. A patient who stopped because the medication made them dizzy is not helped by receiving it more conveniently, and continuing to send it is mildly insulting.
And it does not verify anything clinically. The package contains what a pharmacist released. If the prescription was wrong, the packaging is wrong, neatly.
Frequently asked
- What is multi-dose packaging?
- Multi-dose packaging places all the medications a patient takes at one administration time into a single sealed, labelled package — so a patient taking six medications across four times of day receives four packages per day rather than managing six containers. Each package carries the patient, the contents and the time it is due.
- What is the difference between multi-dose and unit-dose packaging?
- Multi-dose packages everything due at one time together, organised around the administration moment. Unit-dose packages a single dose of a single medication separately, organised around the drug. Multi-dose suits stable regimens and supervised administration; unit-dose suits settings where medications change frequently or need to be given individually, such as an acute hospital ward.
- When is multi-dose packaging a bad idea?
- When regimens change frequently, because every change invalidates the packages already made and the informal fix — opening a sealed package to remove a tablet — destroys the integrity the format provided. Also for as-needed medications, which do not belong to a scheduled time and end up managed separately, and for products that cannot be safely co-packaged because they are hygroscopic, light-sensitive or required to stay in original packaging.
- Does multi-dose packaging improve medication adherence?
- It addresses one of the four reasons patients stop — forgetting or mis-sorting — and not the other three. A side-effect, cost, or a considered decision that the medication is unnecessary are unaffected by more convenient delivery. Packaging also confirms only that a package was opened, not that a dose was taken, which is why it works better combined with contact than instead of it.